Douglas O Escrivani
Encapsulation in lipid-core nanocapsules improves topical treatment with the potent antileishmanial compound CH8
Escrivani, Douglas O; Lopes, Milene Valéria; Poletto, Fernanda; Ferrarini, Stela Regina; Sousa-Batista, Ariane J.; Steel, Patrick G.; Guterres, Sílvia Stanisçuaski; Pohlmann, Adriana Raffin; Rossi-Bergmann, Bartira
Authors
Milene Valéria Lopes
Fernanda Poletto
Stela Regina Ferrarini
Ariane J. Sousa-Batista
Professor Patrick Steel p.g.steel@durham.ac.uk
Professor
Sílvia Stanisçuaski Guterres
Adriana Raffin Pohlmann
Bartira Rossi-Bergmann
Abstract
Cutaneous leishmaniasis (CL) is a neglected parasitic disease conventionally treated by multiple injections with systemically toxic drugs. Aiming at a more acceptable therapy, we developed lipid-core nanocapsules (LNCs) entrapping the potent antileishmanial chalcone (CH8) for topical application. Rhodamine-labeled LNC (Rho-LNC-CH8) was produced for imaging studies. LNC-CH8 and Rho-LNC-CH8 had narrow size distributions (polydispersity index <0.10), with similar mean sizes (~180 nm) by dynamic light scattering. In vitro, Rho-LNC-CH8 was rapidly internalized by extracellular Leishmania amazonensis parasites macrophages in less than 15 min. LNC-CH8 activated macrophage oxidative mechanisms more efficiently than CH8, and was more selectively toxic against the intracellular parasites. In vivo, topically applied Rho-LNC-CH8 efficiently permeated mouse skin. In L. amazonensis-infected mice, LNC-CH8 reduced the parasite load by 86% after three weeks of daily topical treatment, while free CH8 was ineffective. In conclusion, LNC-CH8 has strong potential as a novel topical formulation for CL treatment.
Citation
Escrivani, D. O., Lopes, M. V., Poletto, F., Ferrarini, S. R., Sousa-Batista, A. J., Steel, P. G., Guterres, S. S., Pohlmann, A. R., & Rossi-Bergmann, B. (2020). Encapsulation in lipid-core nanocapsules improves topical treatment with the potent antileishmanial compound CH8. Nanomedicine: Nanotechnology, Biology and Medicine, 24, Article 102121. https://doi.org/10.1016/j.nano.2019.102121
Journal Article Type | Article |
---|---|
Online Publication Date | Oct 28, 2019 |
Publication Date | Feb 28, 2020 |
Deposit Date | Nov 26, 2019 |
Publicly Available Date | Oct 28, 2020 |
Journal | Nanomedicine: Nanotechnology, Biology and Medicine |
Print ISSN | 1549-9634 |
Publisher | Elsevier |
Peer Reviewed | Peer Reviewed |
Volume | 24 |
Article Number | 102121 |
DOI | https://doi.org/10.1016/j.nano.2019.102121 |
Public URL | https://durham-repository.worktribe.com/output/1282729 |
Files
Accepted Journal Article
(4.8 Mb)
PDF
Publisher Licence URL
http://creativecommons.org/licenses/by-nc-nd/4.0/
Copyright Statement
© 2020 This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/
You might also like
TREATMENT OF LEISHMANIASIS
(2024)
Patent
Synthesis and vectorial functionalisation of pyrazolo[3,4- c ]pyridines
(2023)
Journal Article
Downloadable Citations
About Durham Research Online (DRO)
Administrator e-mail: dro.admin@durham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search